Dc-Funds-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "TCRX",
  "BRNS",
  "HOWL"
]

13F-HR • 2025-03-31

Data Enrichment

100% identified

3 identified0 unidentified

Holdings

Manager:

3 positions • $2.1M total value

Manager:

Search and click to pin securities to the top

Sort by:

TScan Therapeutics, Inc.

Shares:630.0K

Value:$869.4K

% of Portfolio:42.1% ($869.4K/$2.1M)

Barinthus Biotherapeutics plc.

Shares:642.2K

Value:$624.7K

% of Portfolio:30.2% ($624.7K/$2.1M)

Werewolf Therapeutics, Inc.

Shares:589.1K

Value:$572.7K

% of Portfolio:27.7% ($572.7K/$2.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
TScan Therapeutics, Inc.(TCRXcusip89854M101)	630.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$869.4K	42.1% ($869.4K/$2.1M)	QoQ -54.60% (-$1.0M) YoY -82.61% (-$4.1M)
Barinthus Biotherapeutics plc.(BRNScusip91864C107)	642.2K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$624.7K	30.2% ($624.7K/$2.1M)	QoQ -19.47% (-$151.1K) YoY -59.13% (-$903.8K)
Werewolf Therapeutics, Inc.(HOWLcusip95075A107)	589.1K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$572.7K	27.7% ($572.7K/$2.1M)	QoQ -34.31% (-$299.1K) YoY -84.99% (-$3.2M)